CAW
KERX

Cornerstone Advisors (Washington)’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Cornerstone Advisors (Washington)’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,202
Closed -$4K – 938
2015
Q3 		$4K Buy
+1,202
New +$4K ﹤0.01% 622